本页面由Tiger Trade Technology Pte. Ltd.提供服务

Contineum Therapeutics, INC.

8.88
-4.5000-33.63%
成交量:402.80万
成交额:4,033.92万
市值:3.34亿
市盈率:-5.16
高:11.51
开:9.85
低:8.43
收:13.38
52周最高:17.79
52周最低:8.43
股本:3,762.11万
流通股本:3,154.15万
量比:18.16
换手率:12.77%
股息:- -
股息率:- -
每股收益(TTM):-1.7201
每股收益(LYR):-2.1700
净资产收益率:-28.01%
总资产收益率:-19.15%
市净率:1.39
市盈率(LYR):-4.09

数据加载中...

2026/10/01

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/09/14

重要事件披露

Form 8-K - Current report
2026/09/08

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/09/01

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/08/14

超过5%披露

Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2026/08/03

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/08/03

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/07/30

重要事件披露

Form 8-K - Current report
2026/07/30

季度报告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2026/07/28

超过5%披露

Form SCHEDULE 13G - Statement of Beneficial Ownership by Certain Investors
2026/07/17

超过5%披露

Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2026/07/14

重要事件披露

Form 8-K - Current report
2026/07/08

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/07/01

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/06/30

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/06/30

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/06/30

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/06/26

重要事件披露

Form 8-K - Current report
2026/06/01

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/05/15

超过5%披露

Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]